Related Experiment Video
Updated: Apr 28, 2026
09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.8K
Melanoma adjuvant therapy.
Ahmad A Tarhini1, Prashanth M Thalanayar2
1Department of Medicine, Division of Hematology-Oncology, University of Pittsburgh Cancer Institute, UPMC Cancer Pavilion, 5150 Centre Avenue (555), Pittsburgh, PA 15232, USA.
Hematology/Oncology Clinics of North America
|June 2, 2014
Summary
Adjuvant therapy for high-risk melanoma aims to cure micrometastases. Interferon-alfa improved survival in trials, offering a key treatment option before advanced disease develops.
Area of Science:
- Oncology
- Dermatology
- Clinical Trials
Background:
- Adjuvant therapy is crucial for surgically resected melanoma with high recurrence risk.
- It offers the best chance for cure before disease progression to advanced stages.
- Melanoma micrometastases are the target of adjuvant treatment strategies.
Purpose of the Study:
- To review current melanoma adjuvant therapy.
- To discuss the impact of interferon-alfa in clinical trials.
- To outline ongoing and planned clinical trials in melanoma adjuvant therapy.
Main Methods:
- Review of randomized clinical trials comparing adjuvant therapies to observation or vaccines.
- Analysis of data on relapse-free survival and overall survival.
- Synthesis of information on interferon-alfa's efficacy.
Main Results:
- Interferon-alfa demonstrated a significant impact on relapse-free survival.
- High-dose interferon-alfa also improved overall survival compared to observation (E1684).
- Interferon-alfa showed improved outcomes compared to the GMK vaccine (E1694).
Conclusions:
- Adjuvant therapy, particularly with interferon-alfa, is effective in managing high-risk melanoma.
- Interferon-alfa offers a viable treatment option for preventing melanoma recurrence.
- Further clinical trials are essential to refine adjuvant treatment strategies.
Related Concept Videos
01:27Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
01:30Skin Cancer
5.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.2K
02:57Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
02:56Treatment Resistant Cancers
2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
02:49Cancer Therapies
8.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.2K